Obesity And Metabolic Syndrome Flashcards
Function of adipose tissue
Insulates, mechanical support for body, secretes adipokines which secrete hormone-like molecules and have an immune fxn and are the body’s main energy reserve
Adipocytes
Fat storing cells that store calories as TGs; hypertrophy which increases fat mass
Major areas of fat storage
SQ tissue, peripheral adipose tissue (subdermal and healthier), visceral adipose tissue (between organs and worse health outcomes)
Adipokines
Have cell-signaling proteins that regulate appetite, coagulation, food intake, energy use, lipid storage, insulin secretion, immune/inflammatory process, coagulation, angiogenesis, fertility, BP, vascular fxn, bone metabolism
Leptin
“Good” adipokine; Adipokines that increase as fat increases; builds resistance with obestity bc leptin controls satiety, if become resistance, you are more likely to overeat and feel less satiated; also works with adiponectin to increase sensitivity to insulin, dec TGs, inhibit fat accumulation, stimulate inflammatory response
Angiopoietin-related protein
Insulin resistance and inflammation
Angiotensinogen
BP, precursor to angio 1 and 2l regulator BP, insulin resistance, inflammation, lipogenesis
Retinol-binding protein
Insulin resistance in muscle
IL-6 and TNFalpha
Biomarkers of inflammation
Adiponectin
Inverse relationship with fat in the body (adiposity); as fat content increases, adiponectin decreases; enhances cell sensitivity to insulin, anti-inflammatory, protects against arteriosclerosis
Measure of obesity
BMI over 30
Obesity puts you at risk for what?
DM2, CVD, cancer, HTN, GERD, arthritis, infection, sleep apnea
Obesogens
Chemicals that contribute to obesity development
Polygenic
Mix of environmental and several genetic mutations that contribute to diabetes like the gene which increases leptin resistance
Risk factors for obesity
Excess caloric intake, sedentary, low SES, age, smoking, genetics, smoking CESSATION, cultural aspects of eating, secondary disease like Cushing’s
BMI calculation
Wt (kg)/h(m)^2 OR wt(lbs)/h(in)^2*703
BMI classifications
Ideal 18.5-24.9; overweight 25-29.9; obese 30-39.9; morbidly obese >40
Ghrelin
Made in the stomach; normally stimulates hunger, controls gastric motility and acid secretion, stimulates GH; decreased in obesity
Glucagon-like peptide (GLP1)
Decreased in obesity; stimulates insulin secretion, inhibits glucagon release, slows gastric emptying, increases satiety
Peptide YY
Decreased in obesity; Dec appetite, inhibits gastric motility, inc energy use (why obese people might feel more fatigued)
Cholecystokinin (CCK)
Probably Dec in obesity (not always decreased); inc satiety, Dec food intake, stimulate gallbladder contraction, pancreatic enzyme release, slows gastric emptying
Obesity and inflammation
Ppl with obesity often in chronic, low-grade inflammatory state; cytokines released bc macrophages, lymphocytes, neutrophils, and mast cells infiltrate adipocytes
FDA approves obesity meds
Orlistat, phentermine/topiramate (appetite suppressant), lorcaserine, naltrexone/bupropior (antidepressant), liraglutide—DPP4 inhibitor injection
Orlistat
OTC med used for obesity